Journal of Pharma and Drug Innovation

Frequency : Bi-Annual (Two issues per year)
Editorial & Review Timeline
3 - 6 Days Initial Quality Review
30 Days Peer Evaluation Summary
45 - 60 Days Complete Editorial Processing Time

Editorial Board

Leonard-Ionut Atanase
Leonard-Ionut Atanase (Ph.D)

Editor-in-Chief

  Full Professor Former Dean

  Faculty of Medical Dentistry

  Apollonia University of Iasi

  Romania

Rana Ahmed Youness
Rana Ahmed Youness (PhD)

Editor-in-Chief

  Assistant Professor of Molecular Genetics and Biochemistry

  Department of Molecular Genetics and Biochemistry

  German International University

  Egypt

Giuseppe Murdaca
Giuseppe Murdaca (MD, PhD)

Editor-in-Chief

  Associate Professor Internal Medicine

  DiMI Department of Internal Medicine

  University of Genova

  Italy

Alireza Heidari
Alireza Heidari (Ph.D)

Editor-in-Chief

  Professor

  Faculty of Chemistry

   California South University (CSU)

  United States (USA)

Institutional Profile Link

Prof Nisar Ullah
Prof Nisar Ullah (PhD)

Editor-in-Chief

  Professor

  Chemistry

  King Fahd University of Petroleum & Minerals

  Saudi Arabia

Mohammad Hasanzadeh
Mohammad Hasanzadeh (PhD)

Editor-in-Chief

  Assistant Professor

  Pharmaceutical Analysis Research Center

  Tabriz University of Medical Sciences

  Iran

Dr Muhammad Ishaq
Dr Muhammad Ishaq (Ph.D)

Editor-Member

  Assistant Research Fellow

  School of Pharmacy

  Shanghai Jiao Tong University

  China

Prof Hani A Alhadrami
Prof Hani A Alhadrami (Ph.D)

Editor-Member

  Professor Consultant of Molecular Diagnostics and Medical Biotechnology

  Medical Biotechnology

  King Abdulaziz University (KAU)

  Saudi Arabia

Ismael Valladolid Acebes
Ismael Valladolid Acebes (Ph.D)

Editor-Member

  Group Leader - Signal Transduction Unit

  Department of Molecular Medicine and Surgery

  Karolinska Institute

  Sweden

Institutional Profile Link

Prof Josiana Adelaide Vaz
Prof Josiana Adelaide Vaz (Ph.D)

Editor-Member

  Department of Diagnostic and Therapeutic Technologies

  Instituto Politécnico de Bragança

  Portugal

Institutional Profile Link

Prof Hamdy Abdelkader
Prof Hamdy Abdelkader (Ph.D)

Editor-Member

  Faculty of Pharmacy

  Faculty of Pharmacy, Minia University

  King Khalid University

  Egypt

Institutional Profile Link

Eleonora Russo
Eleonora Russo (PhD)

Editor-Member

  Associate Professor

  Department of Pharmacy DIFAR

  University of Genoa (UniGe), Italy

  Italy

Institutional Profile Link

Fereshteh Nazari Khanamiri
Fereshteh Nazari Khanamiri (Pharm.D.)

Editor-Member

  Urmia University of Medical Sciences, Urmia, Iran

  Iran

Dr Krishna Chandra Panda
Dr Krishna Chandra Panda (Ph.D)

Editor-Member

  Associate Professor

  Faculty of Pharmacy

  Odisha University of Health Sciences,Berhampur, Odisha

  India

Michal Gorski
Michal Gorski (Ph.D)

Editor-Member

  Assistant Professor

  Department of Chronic Diseases

  Medical University of Silesia in Katowice

  Poland

Institutional Profile Link

Mr Sameer Mustafa Sheikh
Mr Sameer Mustafa Sheikh (M.Pharm)

Editor-Member

  Postgraduate Researcher

  Department of Pharmaceutical Sciences

  Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur

  India

Mr Mohamed Ashraf Momtaz
Mr Mohamed Ashraf Momtaz (Ph.D)

Editor-Member

  PhD Researcher

  Department of Analytical Chemistry

  Faculty of Science, Tanta University

  Egypt

Prof Aura Rusu
Prof Aura Rusu (Ph D)

Editor-Member

  Professor

  Faculty of Pharmacy

  University of Medicine, Pharmacy, Science and Technology of Targu Mures

  Romania

Institutional Profile Link

About the Journal


 

The Journal of Pharma and Drug Innovation (JPDI) is an international, peer-reviewed, open-access journal that publishes high-quality research in pharmaceutical sciences and drug development.

The journal provides a platform for researchers, academicians, pharmacists, and healthcare professionals to share scientific findings and advancements in areas related to drug discovery, development, and therapeutic applications. It supports the dissemination of research that contributes to both fundamental understanding and applied aspects of pharmaceutical sciences.

JPDI covers a broad range of topics including pharmacology, pharmaceutics, pharmacognosy, medicinal chemistry, drug design and delivery, pharmaceutical biotechnology, regulatory science, toxicology, and clinical pharmacy. The journal also encourages interdisciplinary research integrating pharmacy, medicine, chemistry, and life sciences.

The journal publishes original research articles, review articles, short communications, and case studies. All submissions undergo an initial editorial assessment followed by a rigorous peer review process to ensure scientific quality, originality, and relevance.

JPDI operates under an open access model, providing unrestricted access to published content to support the global dissemination of scientific knowledge and research.

Authors are requested to submit manuscripts online at Submit Manuscript or Send as an e-mail attachment to the Editorial Office at editorialoffice@confseries.net

Editorial and Publication Process

ConfSeries Journals is committed to maintaining an efficient, transparent, and quality-focused editorial workflow to support the dissemination of scholarly research.

The journal aims to provide authors with a transparent and structured publication process while ensuring that all submissions undergo appropriate editorial assessment and peer review procedures. Editorial timelines may vary depending on the scope of the manuscript, reviewer availability, revision requirements, and the overall review process.

Authors may choose to publish through the journal's standard publication workflow, which includes editorial screening, peer review, revisions (where required), copyediting, and final publication.

All submissions are evaluated based on scientific quality, originality, ethical compliance, and relevance to the journal's scope. The editorial process is designed to maintain academic integrity and ensure consistency in publication standards.

Accepted manuscripts proceed through production stages including formatting, proof review, DOI assignment, and online publication.

Authors retain the copyright of their published work, and final articles are made available through the journal's open-access publishing model to support global accessibility and scholarly communication.

The journal publishes articles in digital formats suitable for online dissemination and digital accessibility, including PDF and other standard publishing formats where applicable.

The editorial team is committed to following recognized scholarly publishing practices and maintaining transparency throughout the publication process.

Our Peer Review Process

Confseries follows a structured editorial and peer-review process designed to ensure academic quality, ethical integrity, and timely publication. Each manuscript progresses through clearly defined stages,as illustrated in the peer review workflow.

Manuscript Submission
Authors submit their manuscripts through the Confseries submission platform. All submissions must comply with the journal's scope, author instructions, and ethical standards.

Editorial Office Initial Check
Each new submission undergoes an initial assessment by the editorial office to confirm:

  • Relevance to the journal's aims and scope
  • Completeness of required files and declarations
  • Compliance with formatting and submission guidelines
  • Originality through plagiarism screening
  • Absence of major ethical or legal concerns

Manuscripts identified with major plagiarism, duplicate submission, or serious ethical issues are rejected at this stage without external review. Submissions meeting basic requirements proceed to peer review.

Peer Review Initiation

After passing the initial screening:

  • A qualified editor is assigned to the manuscript
  • Independent reviewers are selected based on subject expertise
  • The manuscript is formally sent for peer evaluation
Confseries follows a single-anonymized peer review model to ensure objective and unbiased assessment.

Reviewer Assessment
Reviewers critically evaluate the manuscript focusing on:

  • Scientific originality and relevance
  • Methodological rigor and data integrity
  • Clarity of presentation and organization
  • Ethical compliance and reporting quality
Reviewers submit detailed comments and recommendations to support editorial decision-making.

Editorial Decision
Based on reviewer feedback and editorial evaluation, one of the following decisions is issued:

  • Accepted
  • Minor Revision
  • Major Revision
  • Rejected
Authors receive consolidated comments from both editors and reviewers explaining the decision.

Revision and Re-evaluation
For manuscripts requiring revision:

  • Authors submit a revised manuscript addressing all comments
  • A point-by-point response document is required
  • Major revisions may be reassessed by the original reviewers
Failure to adequately address concerns may result in rejection at this stage.

Acceptance and Publication
Manuscripts accepted for publication proceed to the production phase, which includes:

  • Copyediting and proofreading
  • DOI assignment
  • Final author approval
  • Online publication and dissemination

Ethical and Editorial Integrity

  • Ensuring fair and unbiased peer review
  • Maintaining strict confidentiality of submissions
  • Providing ethical oversight at every editorial stage
  • Ensuring transparent communication with authors with authors

The Confseries peer-review workflow reflects a clear, ethical, and structured editorial process, ensuring that every manuscript is evaluated rigorously before publication.